Prospective, multicentre, non controled, non randomised, clinical study to assess the performance and the stability of SMS femoral stem
Patient suffering from a severely painful and/or disabling hip joint due to osteoarthritis, traumatic arthritis, developmental dysplasia of the hip, or avascular necrosis of the femoral head, and requiring a total hip replacement.
Patient who will receive a Medacta SMS femoral stem.
Patient agrees to comply with the study requirements.
Patient has signed the consent form.
Participation in biomedical research.
Minor patient.
Protected adult patient.
Vulnerable individuals as defined by Article L1121-6 of the Public Health Code.
Medacta International SA
Lead sponsor